140 related articles for article (PubMed ID: 7752122)
1. Modification by oral doxycycline administration of articular cartilage breakdown in osteoarthritis.
Brandt KD
J Rheumatol Suppl; 1995 Feb; 43():149-51. PubMed ID: 7752122
[TBL] [Abstract][Full Text] [Related]
2. Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage.
Smith GN; Yu LP; Brandt KD; Capello WN
J Rheumatol; 1998 Mar; 25(3):532-5. PubMed ID: 9517776
[TBL] [Abstract][Full Text] [Related]
3. Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis.
Yu LP; Burr DB; Brandt KD; O'Connor BL; Rubinow A; Albrecht M
J Rheumatol; 1996 Jan; 23(1):137-42. PubMed ID: 8838522
[TBL] [Abstract][Full Text] [Related]
4. Treatment of osteoarthritis with tiaprofenic acid: biochemical and histological protection against cartilage breakdown in the Pond-Nuki canine model.
Howell DS; Pita JC; Muller FJ; Manicourt DH; Altman RD
J Rheumatol Suppl; 1991 Feb; 27():138-42. PubMed ID: 2027115
[TBL] [Abstract][Full Text] [Related]
5. The influence of doxycycline on articular cartilage in experimental osteoarthrosis induced by iodoacetate.
Cylwik J; Kita K; Barwijuk-Machała M; Reszeć J; Klimiuk P; Sierakowski S; Sulkowski S
Folia Morphol (Warsz); 2004 May; 63(2):237-9. PubMed ID: 15232785
[TBL] [Abstract][Full Text] [Related]
6. Effects of a bisphosphonate on bone histomorphometry and dynamics in the canine cruciate deficiency model of osteoarthritis.
Myers SL; Brandt KD; Burr DB; O'Connor BL; Albrecht M
J Rheumatol; 1999 Dec; 26(12):2645-53. PubMed ID: 10606377
[TBL] [Abstract][Full Text] [Related]
7. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
[TBL] [Abstract][Full Text] [Related]
8. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline.
Yu LP; Smith GN; Brandt KD; Myers SL; O'Connor BL; Brandt DA
Arthritis Rheum; 1992 Oct; 35(10):1150-9. PubMed ID: 1329773
[TBL] [Abstract][Full Text] [Related]
9. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhibition of matrix metalloproteinases on cartilage loss in vitro and in a guinea pig model of osteoarthritis.
Sabatini M; Lesur C; Thomas M; Chomel A; Anract P; de Nanteuil G; Pastoureau P
Arthritis Rheum; 2005 Jan; 52(1):171-80. PubMed ID: 15641085
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors.
Pelletier JP; Lascau-Coman V; Jovanovic D; Fernandes JC; Manning P; Connor JR; Currie MG; Martel-Pelletier J
J Rheumatol; 1999 Sep; 26(9):2002-14. PubMed ID: 10493683
[TBL] [Abstract][Full Text] [Related]
12. The role of cytokines in osteoarthritis pathophysiology.
Fernandes JC; Martel-Pelletier J; Pelletier JP
Biorheology; 2002; 39(1-2):237-46. PubMed ID: 12082286
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of action of nonsteroidal antiinflammatory drugs.
Brandt KD
J Rheumatol Suppl; 1991 Feb; 27():120-1. PubMed ID: 2027109
[TBL] [Abstract][Full Text] [Related]
14. Pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, reduces the progression of experimental osteoarthritis in guinea pigs.
Kobayashi T; Notoya K; Naito T; Unno S; Nakamura A; Martel-Pelletier J; Pelletier JP
Arthritis Rheum; 2005 Feb; 52(2):479-87. PubMed ID: 15692987
[TBL] [Abstract][Full Text] [Related]
15. Licofelone (ML-3000), a dual inhibitor of 5-lipoxygenase and cyclooxygenase, reduces the level of cartilage chondrocyte death in vivo in experimental dog osteoarthritis: inhibition of pro-apoptotic factors.
Boileau C; Martel-Pelletier J; Jouzeau JY; Netter P; Moldovan F; Laufer S; Tries S; Pelletier JP
J Rheumatol; 2002 Jul; 29(7):1446-53. PubMed ID: 12136904
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
[TBL] [Abstract][Full Text] [Related]
17. Induction of an antiinflammatory effect and prevention of cartilage damage in rat knee osteoarthritis by CF101 treatment.
Bar-Yehuda S; Rath-Wolfson L; Del Valle L; Ochaion A; Cohen S; Patoka R; Zozulya G; Barer F; Atar E; Piña-Oviedo S; Perez-Liz G; Castel D; Fishman P
Arthritis Rheum; 2009 Oct; 60(10):3061-71. PubMed ID: 19790055
[TBL] [Abstract][Full Text] [Related]
18. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and mechanism of action of KHBJ-9B, a new herbal medicine, and its major compound triterpenoids in human cartilage culture and in a rabbit model of collagenase-induced osteoarthritis.
Huh JE; Baek YH; Ryu SR; Lee JD; Choi DY; Park DS
Int Immunopharmacol; 2009 Feb; 9(2):230-40. PubMed ID: 19100343
[TBL] [Abstract][Full Text] [Related]
20. Esculetin (dihydroxycoumarin) inhibits the production of matrix metalloproteinases in cartilage explants, and oral administration of its prodrug, CPA-926, suppresses cartilage destruction in rabbit experimental osteoarthritis.
Yamada H; Watanabe K; Saito T; Hayashi H; Niitani Y; Kikuchi T; Ito A; Fujikawa K; Lohmander LS
J Rheumatol; 1999 Mar; 26(3):654-62. PubMed ID: 10090178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
